UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lenvatinib in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver function

Therapeutic advances in medical oncology, 2022, Vol.14, p.17588359221116608-17588359221116608

2022

Volltextzugriff (PDF)

Adjuvant gemcitabine plus docetaxel followed by 5FU chemoradiation for patients with resected pancreaticobiliary cancers: A single-institution, phase II study

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e22243-e22243

Cho, May Thet

2014

Volltextzugriff (PDF)

Phase 1 dose-finding trial of cabozantinib (cabo) and trifluridine/tipiracil (FDT/TPI) in metastatic colorectal carcinoma (mCRC)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.98-98

2023

Volltextzugriff (PDF)

Phase 2 study of cabozantinib (cabo) and pembrolizumab (pembro) in metastatic gastric/gastroesophageal adenocarcinoma (mGEA) refractory to immune checkpoint inhibitors (ICIs)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.345-345

2023

Volltextzugriff (PDF)

A phase Ib multicenter study of trifluridine/tipiracil (FTD/TPI) in combination with irinotecan (IRI) in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma (aGEC) after at least one line of treatment with a fluoropyrimidine and platinum containing regimen

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.TPS251-TPS251

2021

Volltextzugriff (PDF)

A plasma-based analysis and genomic landscape of patients with high tumor mutational burden (TMB-H), microsatellite stable (MSS) colorectal cancer (CRC)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.249-249

2023

Volltextzugriff (PDF)

A pilot study of intratumoral SD-101 (toll-like receptor 9 agonist), nivolumab, and radiotherapy for treatment of chemotherapy-refractory metastatic pancreatic adenocarcinoma

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.TPS782-TPS782

2020

Volltextzugriff (PDF)

Post hoc analysis in patients (pts) with unresectable hepatocellular carcinoma (uHCC) who progressed to Child-Pugh B (CPB) liver function in the phase III REFLECT study of lenvatinib (LEN)

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.298-298

2021

Volltextzugriff (PDF)

A National Cancer Database (NCDB) analysis of the impact of nonmetastatic colon cancer sidedness on survival

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.139-139

2021

Volltextzugriff (PDF)

EA2201: An ECOG-ACRIN phase II study of neoadjuvant nivolumab plus ipilimumab and short course radiation in MSI-H/dMMR rectal tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS3644-TPS3644

2022

Volltextzugriff (PDF)

Association of intermediates of bioenergetic pathways and plasma metabolomics with colorectal cancer (CRC): Diagnosis, stage, and survival

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e15575-e15575

2023

Volltextzugriff (PDF)

Phase I/II trial of BMS-986205 and nivolumab as first-line therapy in hepatocellular carcinoma

Journal of clinical oncology, 2019-03, Vol.37 (8_suppl), p.TPS57-TPS57

2019

Volltextzugriff (PDF)

Variability in multimodality treatment influences survival in non-metastatic gastric cancer patients

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e16588-e16588

2020

Volltextzugriff (PDF)

Plasma central carbon metabolite changes associated with KRAS mutation and circulating tumor DNA (ctDNA) status in colorectal cancer (CRC)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.181-181

2023

Volltextzugriff (PDF)

Prognostic factors in patients with nonmetastatic gastric cancer treated with contemporary multimodality strategies

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.451-451

2020

Volltextzugriff (PDF)

A phase 1b multicenter study of trifluridine/tipiracil (FTD/TPI) in combination with irinotecan (IRI) in patients (pts) with metastatic or unresectable gastric and gastroesophageal adenocarcinoma (mGEC) after at least one line of treatment with a fluoropyrimidine and platinum (FP) containing regimen

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e16006-e16006

2021

Volltextzugriff (PDF)

Prognostic value of circulating tumor DNA (ctDNA) testing in patients (pts) with rectal cancer after neoadjuvant therapy (NAT) and surgery

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.212-212

2024

Volltextzugriff (PDF)

Phase I/II trial of BMS-986205 and nivolumab as first line therapy in hepatocellular carcinoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e16200-e16200

2022

Volltextzugriff (PDF)

Perspectives on under-representation of minority patients (pts) in clinical trials

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18521-e18521

2021

Volltextzugriff (PDF)

A phase I/II study of safety and efficacy of the arginase inhibitor INCB001158 plus chemotherapy in patients (Pts) with advanced biliary tract cancers

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.311-311

2021

Volltextzugriff (PDF)

Phase 2/3, randomized, open-label study of an individualized neoantigen vaccine (self-amplifying mRNA and adenoviral vectors) plus immune checkpoint blockade as maintenance for patients with newly diagnosed metastatic colorectal cancer (GRANITE)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS3635-TPS3635

2022

Volltextzugriff (PDF)

Novel therapeutic strategy to inhibit growth of pancreatic cancer organoids using a rational combination of drugs to induce mitotic arrest and apoptosis

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.322-322

2018

Volltextzugriff (PDF)

The impact of neoadjuvant and/or adjuvant treatment modalities in resectable gastric cancer (rGC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e16564-e16564

2020

Volltextzugriff (PDF)

SGNTV-001: Open label phase 2 study of tisotumab vedotin for locally advanced or metastatic disease in solid tumors

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS3160-TPS3160

2019

Volltextzugriff (PDF)

A pilot study of vinorelbine safety and pharmacokinetics (PKs) in patients (pts) with varying degrees of liver dysfunction (LD)

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.432-432

2018

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(70)
Tagungsberichte
(3)

Sprache

Englisch
(73)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Lenvatinib in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver function

Adjuvant gemcitabine plus docetaxel followed by 5FU chemoradiation for patients with resected pancreaticobiliary cancers: A single-institution, phase II study

Phase 1 dose-finding trial of cabozantinib (cabo) and trifluridine/tipiracil (FDT/TPI) in metastatic colorectal carcinoma (mCRC)

Phase 2 study of cabozantinib (cabo) and pembrolizumab (pembro) in metastatic gastric/gastroesophageal adenocarcinoma (mGEA) refractory to immune checkpoint inhibitors (ICIs)

A phase Ib multicenter study of trifluridine/tipiracil (FTD/TPI) in combination with irinotecan (IRI) in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma (aGEC) after at least one line of treatment with a fluoropyrimidine and platinum containing regimen

A plasma-based analysis and genomic landscape of patients with high tumor mutational burden (TMB-H), microsatellite stable (MSS) colorectal cancer (CRC)

A pilot study of intratumoral SD-101 (toll-like receptor 9 agonist), nivolumab, and radiotherapy for treatment of chemotherapy-refractory metastatic pancreatic adenocarcinoma

Post hoc analysis in patients (pts) with unresectable hepatocellular carcinoma (uHCC) who progressed to Child-Pugh B (CPB) liver function in the phase III REFLECT study of lenvatinib (LEN)

A National Cancer Database (NCDB) analysis of the impact of nonmetastatic colon cancer sidedness on survival

EA2201: An ECOG-ACRIN phase II study of neoadjuvant nivolumab plus ipilimumab and short course radiation in MSI-H/dMMR rectal tumors

Association of intermediates of bioenergetic pathways and plasma metabolomics with colorectal cancer (CRC): Diagnosis, stage, and survival

Phase I/II trial of BMS-986205 and nivolumab as first-line therapy in hepatocellular carcinoma

Variability in multimodality treatment influences survival in non-metastatic gastric cancer patients

Plasma central carbon metabolite changes associated with KRAS mutation and circulating tumor DNA (ctDNA) status in colorectal cancer (CRC)

Prognostic factors in patients with nonmetastatic gastric cancer treated with contemporary multimodality strategies

A phase 1b multicenter study of trifluridine/tipiracil (FTD/TPI) in combination with irinotecan (IRI) in patients (pts) with metastatic or unresectable gastric and gastroesophageal adenocarcinoma (mGEC) after at least one line of treatment with a fluoropyrimidine and platinum (FP) containing regimen

Prognostic value of circulating tumor DNA (ctDNA) testing in patients (pts) with rectal cancer after neoadjuvant therapy (NAT) and surgery

Phase I/II trial of BMS-986205 and nivolumab as first line therapy in hepatocellular carcinoma

Perspectives on under-representation of minority patients (pts) in clinical trials

A phase I/II study of safety and efficacy of the arginase inhibitor INCB001158 plus chemotherapy in patients (Pts) with advanced biliary tract cancers

Phase 2/3, randomized, open-label study of an individualized neoantigen vaccine (self-amplifying mRNA and adenoviral vectors) plus immune checkpoint blockade as maintenance for patients with newly diagnosed metastatic colorectal cancer (GRANITE)

Novel therapeutic strategy to inhibit growth of pancreatic cancer organoids using a rational combination of drugs to induce mitotic arrest and apoptosis

The impact of neoadjuvant and/or adjuvant treatment modalities in resectable gastric cancer (rGC)

SGNTV-001: Open label phase 2 study of tisotumab vedotin for locally advanced or metastatic disease in solid tumors

A pilot study of vinorelbine safety and pharmacokinetics (PKs) in patients (pts) with varying degrees of liver dysfunction (LD)

Suchergebnisse filtern